Skip to main content
Clinical Trials/NCT00005768
NCT00005768
Unknown
Phase 2

Estrogen Modulation of Mood and Cognition Following Monoaminergic Depletion in Post-Menopausal Women

National Center for Research Resources (NCRR)1 site in 1 countryJune 2, 2000
ConditionsMenopause

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Menopause
Sponsor
National Center for Research Resources (NCRR)
Locations
1
Last Updated
20 years ago

Overview

Brief Summary

This study will examine whether estrogen administration in postmenopausal women can alter the response to changes in brain chemistry brought about by dietary manipulation. Women who are recently menopausal (50-60 yrs. of age) and over 20 years postmenopausal (>70 yrs. of age) will take estrogen or placebo for three months. At the end of that time they will participate in three challenges using dietary techniques to briefly change the relative amounts of neurotransmitters in the brain that are believed to be related to mood regulation (serotonin, dopamine, and norepinephrine). Previous research has shown that these dietary manipulations can briefly produce negative changes in mood. The investigator hypothesizes that estrogen administration will blunt or buffer these negative effects in a quantifiable way. The investigator believes that this will provide a direct test of the ability of estrogen to meaningfully change the brain chemistry of mood in a clinically measurable and positive way. The proposed procedure will also allow assessment of the effects of estrogen on brain neurotransmitter systems after many years of very low estrogen levels.

Registry
clinicaltrials.gov
Start Date
June 2, 2000
End Date
TBD
Last Updated
20 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
National Center for Research Resources (NCRR)

Eligibility Criteria

Inclusion Criteria

  • Postmenopausal
  • Non-smoker
  • Without surgically-induced menopause
  • Not on HRT or \>1 year post HRT
  • Normal mammogram within last year
  • No cardiovascular disease other than mild hypertension

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials